Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 11:15 am Purchase | 2024-09-30 | 13G | GT Biopharma, Inc. GTBP | CYTOVANCE BIOLOGICS INC | 219,457 9.800% | 219,457 (New Position) | Filing History |
| 2024-05-23 8:31 pm Purchase | 2024-05-23 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 190,000 8.800% | 179,162 (+1653.09%) | Filing History |
| 2024-02-14 2:46 pm Purchase | 2023-12-31 | 13G | GT Biopharma, Inc. GTBP | ARMISTICE CAPITAL LLC | 2,175,358 4.990% | 2,175,358 (New Position) | Filing History |
| 2023-09-19 11:56 am Purchase | 2023-06-30 | 13G | GT Biopharma, Inc. GTBP | CYTOVANCE BIOLOGICS INC | 91,861 6.800% | 91,861 (New Position) | Filing History |
| 2023-02-14 12:51 pm Purchase | 2022-12-31 | 13G | GT Biopharma, Inc. GTBP | ARMISTICE CAPITAL LLC | 122,540 9.990% | 122,540 (New Position) | Filing History |
| 2022-03-02 9:28 pm Sale | 2022-02-28 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 10,838 1.060% | -28,905 (-72.73%) | Filing History |
| 2022-01-28 5:00 pm Sale | 2021-12-31 | 13G | GT Biopharma, Inc. GTBP | BIGGER CAPITAL FUND L P | 0 0.000% | -48,443 (Position Closed) | Filing History |
| 2022-01-18 11:30 am Sale | 2021-12-31 | 13G | GT Biopharma, Inc. GTBP | Alpha Capital Anstalt | 8,841 0.867% | -2,966 (-25.12%) | Filing History |
| 2021-04-16 07:59 am Purchase | 2021-04-05 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 39,743 4.170% | 26,763 (+206.19%) | Filing History |
| 2021-02-17 4:07 pm Purchase | 2021-02-11 | 13G | GT Biopharma, Inc. GTBP | BIGGER CAPITAL FUND L P | 48,443 7.000% | 48,443 (New Position) | Filing History |
| 2021-02-08 3:08 pm Unchanged | 2020-12-31 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 12,980 7.910% | 0 (Unchanged) | Filing History |
| 2021-02-05 11:10 am Purchase | 2020-12-31 | 13G | GT Biopharma, Inc. GTBP | Alpha Capital Anstalt | 11,807 7.190% | 11,807 (New Position) | Filing History |
| 2020-06-10 08:08 am Purchase | 2020-06-08 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 12,980 9.360% | 5,933 (+84.18%) | Filing History |
| 2020-05-18 4:06 pm Purchase | 2020-05-15 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 7,047 5.080% | 1,132 (+19.14%) | Filing History |